Paul Cordopatis

3.2k total citations
121 papers, 2.6k citations indexed

About

Paul Cordopatis is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Paul Cordopatis has authored 121 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 26 papers in Organic Chemistry and 26 papers in Oncology. Recurrent topics in Paul Cordopatis's work include Chemical Synthesis and Analysis (37 papers), Receptor Mechanisms and Signaling (18 papers) and Peptidase Inhibition and Analysis (10 papers). Paul Cordopatis is often cited by papers focused on Chemical Synthesis and Analysis (37 papers), Receptor Mechanisms and Signaling (18 papers) and Peptidase Inhibition and Analysis (10 papers). Paul Cordopatis collaborates with scholars based in Greece, United States and Canada. Paul Cordopatis's co-authors include Fotini N. Lamari, Marigoula Margarity, Spiros Efthimiopoulos, Θεοδοσία Μάινα, Berthold A. Nock, Athanasios Galanis, E. Manessi‐Zoupa, Georgios A. Spyroulias, Nikos K. Karamanos and Charalabos D. Kanakis and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Biochemistry.

In The Last Decade

Paul Cordopatis

120 papers receiving 2.6k citations

Peers

Paul Cordopatis
Dong Cho Han South Korea
Piyali Dasgupta United States
Thomas Erker Austria
Fajun Nan China
Xun Hu China
Paul Cordopatis
Citations per year, relative to Paul Cordopatis Paul Cordopatis (= 1×) peers Acharan S. Narula

Countries citing papers authored by Paul Cordopatis

Since Specialization
Citations

This map shows the geographic impact of Paul Cordopatis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Cordopatis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Cordopatis more than expected).

Fields of papers citing papers by Paul Cordopatis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Cordopatis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Cordopatis. The network helps show where Paul Cordopatis may publish in the future.

Co-authorship network of co-authors of Paul Cordopatis

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Cordopatis. A scholar is included among the top collaborators of Paul Cordopatis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Cordopatis. Paul Cordopatis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Κουτσιούμπα, Μαρίνα, Constantinos M. Mikelis, Panagiotis Katsoris, et al.. (2012). Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin. PubMed. 4(1). 4–4. 35 indexed citations
2.
Μάινα, Θεοδοσία, Renzo Cescato, Beatrice Waser, et al.. (2012). [111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study. EJNMMI Research. 2(1). 25–25. 22 indexed citations
3.
Tsachaki, Maria, et al.. (2011). Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behavioural Brain Research. 219(2). 197–204. 161 indexed citations
4.
Mikelis, Constantinos M., Μαργαρίτα Λάμπρου, Μαρίνα Κουτσιούμπα, et al.. (2011). A peptide corresponding to the C‐terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro. Journal of Cellular Biochemistry. 112(6). 1532–1543. 25 indexed citations
5.
Lamari, Fotini N., et al.. (2011). A new validated SPE-HPLC method for monitoring crocetin in human plasma—Application after saffron tea consumption. Journal of Pharmaceutical and Biomedical Analysis. 55(3). 563–568. 45 indexed citations
6.
Kotsakis, Αthanasios, Eleni‐Kyriaki Vetsika, Dora Hatzidaki, et al.. (2011). Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study. Annals of Oncology. 23(2). 442–449. 44 indexed citations
7.
Zompra, Aikaterini A., Zoi Diamantopoulou, George Pairas, et al.. (2010). Enzymatic stability, solution structure, and antiproliferative effect on prostate cancer cells of leuprolide and new gonadotropin-releasing hormone peptide analogs. Biopolymers. 96(3). 260–272. 15 indexed citations
8.
Karamanos, Nikos K., et al.. (2010). Crocetin Inhibits Invasiveness of MDA‐MB‐231 Breast Cancer Cells via Downregulation of Matrix Metalloproteinases. Planta Medica. 77(2). 146–151. 73 indexed citations
9.
Vamvakas, Sotirios–Spyridon, et al.. (2009). Folding in solution of the C‐catalytic protein fragment of angiotensin‐converting enzyme. Journal of Peptide Science. 15(8). 504–510. 2 indexed citations
10.
Δάλκας, Γεώργιος, Damien Marchand, Jean‐Claude Galleyrand, et al.. (2009). Study of a lipophilic captopril analogue binding to angiotensin I converting enzyme. Journal of Peptide Science. 16(2). 91–97. 24 indexed citations
12.
Fragiadaki, Maria, Vassiliki Magafa, Lenka Borovičková, Jiřina Slaninová, & Paul Cordopatis. (2007). Synthesis and biological activity of oxytocin analogues containing conformationally-restricted residues in position 7. European Journal of Medicinal Chemistry. 42(6). 799–806. 12 indexed citations
13.
Mavroudis, Dimitriοs, Sébastien Cornet, Peggy Kanellou, et al.. (2006). A Phase I Study of the Optimized Cryptic Peptide TERT<sub>572Y</sub> in Patients with Advanced Malignancies. Oncology. 70(4). 306–314. 47 indexed citations
14.
Dai, Yang, Daniel McCormick, Yi-chi M. Kong, et al.. (2005). Thyroxine-Binding Antibodies Inhibit T Cell Recognition of a Pathogenic Thyroglobulin Epitope. The Journal of Immunology. 174(5). 3105–3110. 12 indexed citations
15.
Nikolopoulou, Anastasia, et al.. (2005). Tetraamine‐modified octreotide and octreotate: labeling with 99mTc and preclinical comparison in AR4‐2J cells and AR4‐2J tumor‐bearing mice. Journal of Peptide Science. 12(2). 124–131. 6 indexed citations
16.
Saroglou, Vasiliki, Sophia Hatziantoniou, Ioanna Kyrikou, et al.. (2005). Synthesis, liposomal formulation and thermal effects on phospholipid bilayers of leuprolide. Journal of Peptide Science. 12(1). 43–50. 12 indexed citations
17.
Gabriel, Michael, Clemens Decristoforo, Θεοδοσία Μάινα, et al.. (2004). 99m Tc-N 4 -[Tyr 3 ]Octreotate Versus 99m Tc-EDDA/HYNIC-[Tyr 3 ]Octreotide: An Intrapatient Comparison of Two Novel Technetium-99m Labeled Tracers for Somatostatin Receptor Scintigraphy. Cancer Biotherapy and Radiopharmaceuticals. 19(1). 73–79. 24 indexed citations
18.
Galanis, Athanasios, Georgios A. Spyroulias, Roberta Pierattelli, et al.. (2003). Zinc binding in peptide models of angiotensin‐I converting enzyme active sites studied through 1H‐NMR and chemical shift perturbation mapping. Biopolymers. 69(2). 244–252. 6 indexed citations
19.
Matsoukas, John, et al.. (1991). Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine. International journal of peptide & protein research. 37(1). 21–26. 1 indexed citations
20.
Stavropoulos, George, Paul Cordopatis, David Halle, et al.. (1991). Synthesis and biological activity of Substance PC‐terminal hexapeptide and heptapeptide analogues. International journal of peptide & protein research. 37(3). 180–184. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026